达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DVA 达维塔保健

未开盘 12-20 15:59:59 EST

151.89

+4.35

+2.95%

盘后151.85

+0.000.00%

18:05 EST

最高153.40	最低147.58	成交量179.33万
今开148.43	昨收147.54	日振幅3.94%
总市值124.55亿	流通市值64.26亿	总股本8,200万
成交额2.72亿	换手率4.24%	流通股本4,230万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"DVA","market":"US","secType":"STK","nameCN":"达维塔保健","latestPrice":151.89,"timestamp":1734728399409,"preClose":147.54,"halted":0,"volume":1793316,"hourTrading":{"tag":"盘后","latestPrice":151.85,"preClose":151.85,"latestTime":"18:05 EST","volume":299188,"amount":45431690.36812,"timestamp":1734735930593},"delay":0,"floatShares":42304439,"shares":82000000,"eps":9.244524,"marketStatus":"未开盘","marketStatusCode":0,"change":4.35,"latestTime":"12-20 15:59:59 EST","open":148.43,"high":153.4,"low":147.58,"amount":272304920.29776,"amplitude":0.039447,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":9.244524,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":815029200000,"adjPreClose":147.54,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":147.35,"preClose":147.54,"latestTime":"09:29 EST","volume":169,"amount":24926.32714,"timestamp":1734704994091},"postHourTrading":{"tag":"盘后","latestPrice":151.85,"preClose":151.85,"latestTime":"18:05 EST","volume":299188,"amount":45431690.36812,"timestamp":1734735930593},"volumeRatio":2.1270804736191082,"impliedVol":0.3161,"impliedVolPercentile":0.232},"requestUrl":"/m/hq/s/DVA/tweets","defaultTab":"tweets","newsList":[{"id":"1182484165","title":"为什么沃伦·巴菲特的伯克希尔·哈撒韦现金储备持续膨胀？","url":"https://stock-news.laohu8.com/highlight/detail?id=1182484165","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182484165?lang=zh_cn&edition=full","pubTime":"2024-11-05 09:35","pubTimestamp":1730770501,"startTime":"0","endTime":"0","summary":"展望未来，伯克希尔·哈撒韦最近刚刚加入了市值达万亿美元的俱乐部，并在这个周末冻结了股票回购，这可能进一步增加其巨额现金储备。需要注意的是，在当前利率环境下，这笔现金储备为伯克希尔带来了35亿美元的收益，这与其现金和国债头寸相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052756011.USD","AXP","OXY","BRK.A","MCO","LU0053666078.USD","BRK.B","DVA","C","IE00BJTD4V19.USD","KO","AAPL","AXP.AU","LU1988902786.USD","SIRI","IE00BVYPNW00.USD","CB","BAC","CVX","KHC"],"gpt_icon":1},{"id":"2480758518","title":"德维特2024财年第三财季实现净利润2.15亿美元，同比减少12.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480758518","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480758518?lang=zh_cn&edition=full","pubTime":"2024-11-03 00:01","pubTimestamp":1730563278,"startTime":"0","endTime":"0","summary":"11月3日，德维特公布财报，公告显示公司2024财年第三财季净利润为2.15亿美元，同比减少12.96%；其中营业收入为32.64亿美元，同比增加4.58%，每股基本收益为2.56美元。从资产负债表来看，德维特总负债152.84亿美元，其中短期债务7.01亿美元，资产负债比为1.15，流动比率为1.38。机构评级：截至2024年11月3日，当前有7家机构对德维特目标价做出预测，其中目标均价为163.71美元，其中最低目标价为145.00美元，最高目标价为186.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241103000206ab98f56b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DVA"],"gpt_icon":0},{"id":"1118458400","title":"异动解读 | 达维塔保健高昂医疗成本引发业绩下滑 股价暴跌12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1118458400","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118458400?lang=zh_cn&edition=full","pubTime":"2024-10-31 05:20","pubTimestamp":1730323259,"startTime":"0","endTime":"0","summary":"透析服务商达维塔保健股价在10月30日盘中出现12.67%的暴跌,引发市场广泛关注。这一暴跌主要归咎于公司第三季度业绩不佳、利润大幅下滑。达维塔保健当日公布的最新财报显示,第三季度公司营收32.6亿美元,符合预期。数据显示,该季度达维塔保健每次治疗病人的护理成本达到257.46美元,同比有所上涨。但本季度这一成本的失控导致公司利润率水平大幅下滑,引发投资者对其未来业绩前景的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1194614074","title":"异动解读 | 达维塔保健(DVA)业绩不佳导致股价盘中暴跌6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194614074","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194614074?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:37","pubTimestamp":1730295430,"startTime":"0","endTime":"0","summary":"达维塔保健在2024年10月30日盘中出现6.66%的暴跌,引起了市场的广泛关注。暴跌主要原因在于公司于前一日晚间公布了第三季度财报,营收略低于预期且利润严重下滑。造成利润大幅下滑的主要原因是公司的薪酬、医疗福利和其他患者护理相关费用在本季度显著增加,导致患者护理成本大幅上升。数据显示,达维塔保健第三季度每次治疗病人的护理成本为257.46美元,同比上涨。投资者对公司业绩前景的看空预期最终导致股价在30日盘中暴跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"2479264783","title":"德维特盘中异动 早盘股价大跌8.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479264783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479264783?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:32","pubTimestamp":1730295133,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时32分，德维特股票出现波动，股价大幅下挫8.56%。截至发稿，该股报144.76美元/股，成交量4.5854万股，换手率0.06%，振幅2.82%。德维特股票所在的医疗设施行业中，整体跌幅为0.48%。德维特公司简介：达维塔保健是美国最大的透析服务提供商，按患者和诊所计算，其市场份额超过 35%。该公司在全球拥有 3,000 多家设施，大部分位于美国，每年在全球治疗约 250,000 名患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021321495bd8e15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021321495bd8e15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","DVA","BK4559","BK4585","BK4588"],"gpt_icon":0},{"id":"1133272896","title":"异动解读 | 达维塔保健高昂的护理成本引发股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1133272896","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133272896?lang=zh_cn&edition=full","pubTime":"2024-10-30 20:30","pubTimestamp":1730291449,"startTime":"0","endTime":"0","summary":"达维塔保健在10月30日美股夜盘交易中出现6.2%的大跌,引发了市场的广泛关注。这一暴跌的主要原因在于该公司第三季度财报中显示,高昂的患者护理成本正在严重侵蚀公司的利润水平。作为一家领先的透析服务提供商,病人护理成本是达维塔保健最主要的运营支出。具体来看,达维塔保健第三季度营收32.6亿美元,符合分析师预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1175994484","title":"异动解读 | 达维塔保健股价暴跌 病人护理成本上涨引发业绩下滑担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1175994484","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175994484?lang=zh_cn&edition=full","pubTime":"2024-10-30 13:54","pubTimestamp":1730267688,"startTime":"0","endTime":"0","summary":"达维塔保健在10月30日美股夜盘交易中出现5.94%的大跌,引发了市场的广泛关注。根据公司第三季度财报,这一下跌或许与业绩和成本问题有关。据了解,透析企业的主要成本支出在于患者护理开支。达维塔保健的财报数据显示,每次治疗的病人护理成本从第二季度的255.25美元上涨到257.46美元。上涨的护理成本使公司利润受到严重压缩,利润率水平下滑。预计护理成本居高不下的问题在第四季度仍将持续。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1189201121","title":"异动解读 | 达维塔保健业绩令人失望 股价盘后大跌6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1189201121","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189201121?lang=zh_cn&edition=full","pubTime":"2024-10-30 11:06","pubTimestamp":1730257602,"startTime":"0","endTime":"0","summary":"达维塔保健(DVA)今日盘后股价大跌6.01%,引发了市场的广泛关注。公司此前公布的第三季度财报显示,由于病人护理成本持续上升,第三季度利润不及华尔街预期。\n\n根据统计数据,达维塔保健第三季度调整后每股利润为2.59美元,低于分析师预期的2.73美元。这主要归因于薪酬、医疗福利等患者护理相关支出的大幅增长,已经严重拖累了公司的利润水平。\n\n另一方面,达维塔保健本季度关闭了部分美国透析中心,产生了约1800多万美元的关闭费用,并增加了350万美元的患者护理成本。此外,公司还预计由于供应链断裂导致的透析产品短缺问题将影响其第四季度的业绩表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"1101224527","title":"异动解读 | 达维塔保健第三季度利润低于预期,成本增加拖累业绩 股价盘后大跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1101224527","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101224527?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:53","pubTimestamp":1730235214,"startTime":"0","endTime":"0","summary":"达维塔保健(DVA)今日盘后股价大跌6.01%,引发了市场的广泛关注。\n公司此前公布的第三季度财报显示,由于病人护理成本持续高企,第三季度利润不及华尔街预期。根据LSEG统计,达维塔保健第三季度调整后每股利润为2.59美元,低于分析师预期的2.73美元。\n虽然公司重申了全年利润预期为每股9.25美元至10.05美元,但投资者显然对公司业绩面临的成本压力感到担忧。作为透析诊所运营商,病人护理开支是达维塔保健最主要的成本支出。如果护理成本持续居高不下,将严重影响公司的利润率水平。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["DVA"],"gpt_icon":0},{"id":"2479644172","title":"更新版 3-透析公司 DaVita 第三季度利润低于预期，原因是成本增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2479644172","media":"路透中文","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479644172?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:26","pubTimestamp":1730233576,"startTime":"0","endTime":"0","summary":"DaVita 还表示，预计近期飓风造成的干扰影响很小。DaVita 预计，高昂的供应成本和较低的新患者开诊率将对第四季度业绩造成 1,000 万至 2,000 万美元的影响。DaVita 公布的季度收入为 32.6 亿美元，分析师预计为 32.5 亿美元。在截至 9 月 30 日的三个月内，DaVita 因关闭美国透析中心而产生了约 1830 万美元的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nL4S3M52KU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0211327993.USD","LU0211328371.USD","LU2098885051.SGD","BAX","BK4559","BK4588","LU1267930490.SGD","LU0310799852.SGD","BK4196","DVA","LU0006061336.USD","BK4585","LU1303367103.USD","BK4504"],"gpt_icon":0},{"id":"2479252254","title":"更新版 1-透析公司 DaVita 第三季度利润低于预期，原因是成本增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2479252254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479252254?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:26","pubTimestamp":1730233576,"startTime":"0","endTime":"0","summary":"     路透10月29日 -    透析公司DaVita   周二公布的第三季度利润不及华尔街预期，受病人护理成本高企的影响。收盘后，该公司股价下跌7.1%，报147美元。根据 LSEG 统计的数据，调整后的第三季度利润为每股 2.59 美元，低于分析师预计的每股 2.73 美元。该公司重申其年度利润预期为每股 9.25 美元至 10.05 美元。DaVita 公布的季度收入为 32.6 亿美元，与分析师预计的 32.5 亿美元基本一致。DaVita 通过门诊诊所网络和居家透析服务，为美国慢性肾衰竭患者提供肾脏护理服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930490.SGD","BK4585","LU0234572021.USD","IE00B3PB1722.GBP","LU0114720955.EUR","LU1221951046.USD","IE0009355771.USD","IE00B42XCP33.USD","JNJ","LU0211328371.USD","LU0912757837.SGD","LU0211327993.USD","BK4559","BK4568","LU0640476718.USD","IE00B4R5TH58.HKD","IE000M9KFDE8.USD","LU0345770993.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LU2098885051.SGD","BK4082","LU0792757196.USD","BK4196","LU1303367103.USD","BK4550","IE00BVYPNW00.USD","LU0203347892.USD","LU0310799852.SGD","LU0203345920.USD","IE00BVYPNV92.GBP","LU1221951129.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","LU1074936037.SGD","BAX","LU0122379950.USD","LU1196500208.SGD","IE00BSNM7G36.USD","LU0234570918.USD","DVA","LU0006061336.USD","LU1066051498.USD","LU0345769128.USD","IE00B19Z3581.USD","BK4581","LU1066051225.USD","IE00B1BXHZ80.USD","LU0345769631.USD","LU0882574055.USD"],"gpt_icon":0},{"id":"2479250987","title":"更新版 2-透析公司 DaVita 第三季度利润低于预期，原因是成本增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2479250987","media":"路透中文","labels":["express","preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479250987?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:26","pubTimestamp":1730233576,"startTime":"0","endTime":"0","summary":"更新版 2-透析公司 DaVita 第三季度利润低于预期，原因是成本增加第 7-9 段增加了有关业绩的详细信息路透10月29日 - 透析公司DaVita DVA.N周二公布的第三季度利润低于华尔街 预期，受劳动力成本和其他患者护理相关费用增加的影响，股价 盘后下跌7%。DaVita 公布的季度收入为 32.6 亿美元，与分析师预计的 32.5 亿美元基本一致。在截至 9 月 30 日的三个月内，DaVita 因关闭美国透析中心而产生了约 1830 万美元的费用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nL4S3M52KU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"更新版 2-透析公司 DaVita 第三季度利润低于预期，原因是成本增加","news_tag":"express,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA","BK4559","BK4585","BK4196","BK4588"],"gpt_icon":0},{"id":"2479304254","title":"由于成本增加，DaVita 第三季度利润低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2479304254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479304254?lang=zh_cn&edition=full","pubTime":"2024-10-30 04:19","pubTimestamp":1730233196,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透10月29日 - 本周二，DaVita   公布的第三季度利润低于华尔街预期，主要是受到高昂的病人护理成本的影响。经调整后，该公司第三季度每股利润为2.59美元，低于分析师预计的每股2.73美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","IE00B4R5TH58.HKD","LU0795875086.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1074936037.SGD","IE0002270589.USD","BK4585","LU0310799852.SGD","LU0345769631.USD","LU1303367103.USD","IE00BVYPNV92.GBP","LU0889566641.SGD","LU1196500208.SGD","BAX","LU0098860793.USD","LU1057294990.SGD","BK4534","BK4581","IE00B7SZLL34.SGD","LU1162221912.USD","IE00BFTCPJ56.SGD","IE00BDGV0183.EUR","LU1059921491.USD","LU0203347892.USD","JNJ","BK4532","LU0912757837.SGD","LU0466842654.USD","LU0345769128.USD","LU0203345920.USD","LU1032955483.USD","BK4592","LU0795875169.SGD","LU0122379950.USD","BK4504","BK4568","DVA","LU2098885051.SGD","BK4559","LU0792757196.USD","IE00B19Z3581.USD","LU0234572021.USD","LU1066053197.SGD","IE00BVYPNW00.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BK4588"],"gpt_icon":0},{"id":"2466201155","title":"美国研究综述-Cintas、Sprouts Farmers Market、Voya Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2466201155","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466201155?lang=zh_cn&edition=full","pubTime":"2024-09-12 22:48","pubTimestamp":1726152522,"startTime":"0","endTime":"0","summary":"    路透9月12日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Cintas Corp、Sprouts Farmers market 和 Voya Financial。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRDG","CTRA","CSBR","EQIX","AR","BKH","EIX","AN","AVA","FANG","CTAS","ARMK","BX","CNX","SCHW","LU","BLK","DVN","ARI","ALHC","EQT","APA","ABG","OWL","ALLY","LU0300736062.USD","DVA","DBI","CPB","AMAT","IE00BBT3K403.USD","CG","ARES","BK4231","CVNA","AAP","LU1894683348.USD","BNTC","EFX","IE000M9KFDE8.USD","AMT","APO","CNP","EOG","BRX","EA","LU0321505868.SGD","ELF"],"gpt_icon":1},{"id":"2458337697","title":"德维特2024财年第二财季实现净利润2.23亿美元，同比增加24.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458337697","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458337697?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:17","pubTimestamp":1723393057,"startTime":"0","endTime":"0","summary":"8月12日，德维特公布财报，公告显示公司2024财年第二财季净利润为2.23亿美元，同比增加24.58%；其中营业收入为31.87亿美元，同比增加6.23%，每股基本收益为2.56美元。机构评级：截至2024年8月12日，当前有8家机构对德维特目标价做出预测，其中目标均价为148.95美元，其中最低目标价为123.50美元，最高目标价为175.00美元。公司简介：德维特是美国最大的透析服务提供商，按患者和诊所计算，其市场份额都超过35%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001748959046fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812001748959046fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DVA"],"gpt_icon":0},{"id":"2458552682","title":"超70亿！透析巨头撬动全球版图","url":"https://stock-news.laohu8.com/highlight/detail?id=2458552682","media":"思宇MedTech","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458552682?lang=zh_cn&edition=full","pubTime":"2024-08-09 17:35","pubTimestamp":1723196125,"startTime":"0","endTime":"0","summary":"2017年时，DaVita将DaVita Medical Group以43亿美元出售给联合健康集团的Optum部门。截至2023年12月31日，公司在美国运营2675家独立透析中心，还在790家医院内为住院病人提供透析服务。2024年8月6日，公司发布第二季度最新财报信息：合并收入为31.87亿美元，营业收入为5.06亿美元。# 积极合作2017年，DaVita与华润医疗签署战略合作协议，共同开发中国透析市场。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408091748389f1d43d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408091748389f1d43d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B3S45H60.SGD","LU0154236417.USD","IE0034235303.USD","BK4550","LU0234570918.USD","LU1201861249.SGD","LU1074936037.SGD","LU0971096721.USD","LU1366333091.USD","BK4585","LU1571399168.USD","BK4196","LU0048573561.USD","IE00BKDWB100.SGD","RCS","BK4533","BK4176","IE00BWXC8680.SGD","IE00B1BXHZ80.USD","LU0157215616.USD","LU0251142724.SGD","LU0742534661.SGD","IE00B1XK9C88.USD","LU1363072403.SGD","BK4534","BK4581","IE00B775SV38.USD","LU1280957306.USD","LU1914381329.SGD","IE00BK4W5L77.USD","LU0980610538.SGD","LU0683600562.USD","LU0251131958.USD","LU0149725797.USD","BK4023","LU0256863811.USD","LU0640476718.USD","LU0787776722.HKD","HCP","DVA","BK4559","LU0648001328.SGD","LU0234572021.USD","IE00BK4W5M84.HKD","LU0053666078.USD","LU0417517546.SGD","LU0130102774.USD","BK4588"],"gpt_icon":1},{"id":"2457885869","title":"达维塔公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457885869","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457885869?lang=zh_cn&edition=full","pubTime":"2024-08-07 06:15","pubTimestamp":1722982511,"startTime":"0","endTime":"0","summary":"   * DaVita Inc   公布的截至6月底的季度调整后每股收益为2.50美元，高于去年同期的每股收益1.91美元。六位分析师对该季度的平均预期为每股收益 2.54 美元。* DaVita Inc 公布的本季度每股收益为 2.50 美元。* 公司报告的季度净收入为 2.2268 亿美元。* 本季度，DaVita Inc 的股价下跌了 2.3%，今年迄今为止上涨了 29.3%。华尔街对 DaVita Inc 的 12 个月目标价中位数为 150.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA","BK4585","BK4559","BK4588","BK4196"],"gpt_icon":0},{"id":"2456616052","title":"达维塔公司  预计每股收益2.54美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456616052","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456616052?lang=zh_cn&edition=full","pubTime":"2024-08-03 06:28","pubTimestamp":1722637681,"startTime":"0","endTime":"0","summary":"   * 达维塔公司   将于8月6日公布截至2024年6月30日的财报，预计季度收入将有所增长。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于科罗拉多州丹佛市的公司的营收将从去年同期的30亿美元增长5.1%，达到31.52亿美元。* LSEG 分析师对 DaVita Inc 的平均预期为每股收益 2.54 美元。* 华尔街对 DaVita Inc 的 12 个月目标价中位数为 150.00 美元，高于其上次收盘价 139.52 美元。8月2日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔公司  预计每股收益2.54美元 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"gpt_icon":0},{"id":"2454209867","title":"TD Cowen：维持DaVita(DVA.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2454209867","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454209867?lang=zh_cn&edition=full","pubTime":"2024-07-25 09:31","pubTimestamp":1721871103,"startTime":"0","endTime":"0","summary":"TD Cowen：维持DaVita(DVA.US)评级，由持有调整至持有评级,目标价由139.00美元调整至150.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250947129558479e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407250947129558479e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TD","DVA"],"gpt_icon":0},{"id":"2451997985","title":"道指涨0.5%，标普500指数涨0.3%，纳指涨0.3%。特朗普媒体科技集团跌约10%，前一交易日收涨逾31%。特斯拉涨约1%，报道称马斯克计划每月投入4500万美元以支持特朗普大选。","url":"https://stock-news.laohu8.com/highlight/detail?id=2451997985","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451997985?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:33","pubTimestamp":1721136798,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"live_wallstreetcn","url":"https://wallstreetcn.com/live/a-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/live/a-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_wallstreetcn","symbols":["QID","US12M.BOND","09626",".SPX","DDM","SCHW","159659","IVV","UPRO","TSLL","159503","US912797GL51.BOND","NQmain","SPY","SSO","US912797HE00.BOND","DXD","QQQ","TTTN","HK0000934320.USD","US912797GK78.BOND",".DJI","MNQmain","TSLA","YMmain","ESmain","US2Y.BOND","US6M.BOND","DJT","03086","US30Y.BOND","SQQQ","DJX","US7Y.BOND","QLD","TQQQ","US912797GB79.BOND","OEF","PSQ","DVA","UDOW","US912797GW17.BOND","SH","DOG","US10Y.BOND","BILI","US3Y.BOND",".IXIC","US5Y.BOND","BAC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.davita.com","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":-0.0589},{"period":"3month","weight":-0.0738},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.4499},{"period":"ytd","weight":0.4499}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DaVita Inc.于1994年在特拉华州注册成立，DaVita是一家领先的医疗保健提供商，专注于转变医疗服务以提高全球患者的生活质量。他们是美国最大的肾脏护理服务提供商之一，20多年来一直是临床质量和创新的领导者。DaVita致力于大胆的、以患者为中心的护理模式，实施最新技术并转向综合护理产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.517241,"avgChangeRate":-0.001786},{"month":2,"riseRate":0.482759,"avgChangeRate":-0.017694},{"month":3,"riseRate":0.551724,"avgChangeRate":0.020443},{"month":4,"riseRate":0.655172,"avgChangeRate":0.029621},{"month":5,"riseRate":0.62069,"avgChangeRate":0.020972},{"month":6,"riseRate":0.586207,"avgChangeRate":0.045331},{"month":7,"riseRate":0.551724,"avgChangeRate":-0.00759},{"month":8,"riseRate":0.448276,"avgChangeRate":-0.005446},{"month":9,"riseRate":0.586207,"avgChangeRate":0.018916},{"month":10,"riseRate":0.517241,"avgChangeRate":0.0052},{"month":11,"riseRate":0.6,"avgChangeRate":0.052442},{"month":12,"riseRate":0.6,"avgChangeRate":0.044018}],"exchange":"NYSE","name":"达维塔保健","nameEN":"DaVita HealthCare Partners"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达维塔保健,DVA,达维塔保健股票,达维塔保健股票老虎,达维塔保健股票老虎国际,达维塔保健行情,达维塔保健股票行情,达维塔保健股价,达维塔保健股市,达维塔保健股票价格,达维塔保健股票交易,达维塔保健股票购买,达维塔保健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}